These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Angiopoietins-1 and -2 are both capable of mediating endothelial PAF synthesis: intracellular signalling pathways. Maliba R; Lapointe S; Neagoe PE; Brkovic A; Sirois MG Cell Signal; 2006 Nov; 18(11):1947-57. PubMed ID: 16617006 [TBL] [Abstract][Full Text] [Related]
5. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat. Salari H; Demos M; Wong A Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677 [TBL] [Abstract][Full Text] [Related]
6. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells. Heller R; Bussolino F; Ghigo D; Garbarino G; Pescarmona G; Till U; Bosia A J Immunol; 1992 Dec; 149(11):3682-8. PubMed ID: 1431139 [TBL] [Abstract][Full Text] [Related]
7. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441. Morris DD; Moore JN Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315 [TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. Ma X; Ottino P; Bazan HE; Bazan NG Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102 [TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor (PAF) increases NO production in human endothelial cells-real-time monitoring by DAR-4M AM. Kikuchi M; Shirasaki H; Himi T Prostaglandins Leukot Essent Fatty Acids; 2008; 78(4-5):305-9. PubMed ID: 18502110 [TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees. Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055 [TBL] [Abstract][Full Text] [Related]
11. Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist. Lang CH; Dobrescu C; Hargrove DM; Bagby GJ; Spitzer JJ Circ Shock; 1987; 23(3):179-88. PubMed ID: 3427772 [TBL] [Abstract][Full Text] [Related]
12. Neutrophil-activating activity and platelet-activating factor synthesis in cytokine-stimulated endothelial cells: reduced activity in growth-arrested cells. Takahashi T; Nishizawa Y; Hato F; Shintaku H; Maeda N; Fujiwara N; Inaba M; Kobayashi K; Kitagawa S Microvasc Res; 2007 Jan; 73(1):29-34. PubMed ID: 17027041 [TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor and leukotriene biosynthesis in whole blood. A model for the study of transcellular arachidonate metabolism. Fradin A; Zirrolli JA; Maclouf J; Vausbinder L; Henson PM; Murphy RC J Immunol; 1989 Dec; 143(11):3680-5. PubMed ID: 2555415 [TBL] [Abstract][Full Text] [Related]
18. The role of platelet-activating factor in conscious, normotensive endotoxemia. Ephgrave K; Kremer T; Broadhurst K; Cullen J J Surg Res; 1997 Mar; 68(2):170-4. PubMed ID: 9184676 [TBL] [Abstract][Full Text] [Related]
19. The proangiogenic phenotype of tumor-derived endothelial cells is reverted by the overexpression of platelet-activating factor acetylhydrolase. Doublier S; Ceretto M; Lupia E; Bravo S; Bussolati B; Camussi G Clin Cancer Res; 2007 Oct; 13(19):5710-8. PubMed ID: 17908960 [TBL] [Abstract][Full Text] [Related]
20. Alterations in nitric oxide production in various forms of circulatory shock. Szabó C New Horiz; 1995 Feb; 3(1):2-32. PubMed ID: 7535648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]